To evaluate whether the changes in the blood plasma DPP-IV reflect disease activity in individual patients, a follow-up evaluation was performed in 18 patients with RA during a less active phase of their disease as defined by the regression of joint effusion and improved DAS28 score compared to the entry values. The gene discussed is DPP4; the disease is Joint swelling.